Abstract
THE presentation of intracellular proteins to the immune system requires their degradation to small peptides1,2 that then become associated with major histocompatibility complex (MHC) class I molecules3,4. The generation of these peptides may involve the 20S or 26S proteasome particles, which contain multiple proteolytic activities5—14 including distinct sites that preferentially cleave small peptides on the carboxyl side of hydrophobic, basic or acidic residues6,13,14. Degradation of most cell proteins requires their con-jugation to ubiquitin before hydrolysis by the 26S protea-some6,13—16. This large complex contains the 20S proteasome as its proteolytic core6,14,16—18. This ubiquitin-dependent proteolytic pathway is implicated in MHC class I presentation11,12. γ-Inter-feron (γ-IFN), a stimulator of antigen presentation1, induces a subclass of proteasomes that contain two MHC-encoded subunits, LMP2 and 7 (refs 5—10). Here we show that γ-interferon alters the peptidase activities of the 20S and 268 proteasomes without affecting the rates of breakdown of proteins or of ubiquitinated proteins. By enhancing the expression of MHC genes, γ-IFN increases the proteasomes' capacity to cleave small peptides after hydrophobic and basic residues but reduces cleavage after acidic residues. Moreover, proteasomes of mutants lacking LMP sub-units show decreased rates of cleavage after hydrophobic and basic residues. Thus, γ-IFN and expression of these MHC genes should favour the production by proteasomes of the types of peptides found on MHC class I molecules, which terminate almost exclusively with hydrophobic or basic residues19.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Townsend, A. R. M. & Bodmer, H. A. Rev. Immun. 7, 601–624 (1989).
Morrison, L. A., Lukacher, A., Braciale, V. L., Fan, D. P. & Braciale, T. J. J. exp. Med. 163, 903–921 (1986).
Monaco, J. J. Immun. Today 13, 173–179 (1992).
Spies, T. & DeMars, R. Nature 351, 323–324 (1991).
Driscoll, J. & Finley, D. Cell 68, 823–825 (1992).
Goldberg, A. L. & Rock, K. L. Nature 357, 375–379 (1992).
Martinez, C. K. & Monaco, J. J. Nature 353, 664–667 (1991).
Ortiz-Navarette, V. et al. Nature 353, 662–664 (1991).
Kelly, A. et al. Nature 353, 667–668 (1991).
Brown, M. G., Driscoll, J. & Monaco, J. J. Nature 353, 355–357 (1991).
Michalek, M. T., Grant, E. P., Gramm, C., Goldberg, A. L. & Rock, K. L. Nature 363, 552–554 (1993).
Townsend, A. et al. J. exp. Med. 168, 1211–1224 (1988).
Goldberg, A. L. Eur. J. Biochem. 203, 9–23 (1992).
Rivett, A. J. Archs Biochem. Biophys. 218, 1–8 (1989).
Finley, D. & Chan, V. A. Rev. Cell Biol. 7, 25–69 (1991).
Waxman, L., Fagan, J. M. & Goldberg, A. L. J. biol. Chem. 262, 2451–2457 (1987).
Armon, T., Ganoth, D. & Hershko, A. J. biol. Chem. 265, 20723–20726 (1990).
Driscoll, J. & Goldberg, A. L. J. biol. Chem. 265, 4789–4792 (1990).
Falk, K. & Rotzschke, O. Sem. Immun. 5, 81–94 (1993).
Yang, Y., Waters, J. B., Fruh, R. & Peterson, P. A. Proc. natn. Acad. Sci. U.S.A. 89, 4928–4932 (1992).
DeMars, R. et al. Proc. natn. Acad. Sci. U.S.A. 82, 8183–8187 (1985).
Ahn, J. Y. et al. J. biol. Chem. 266, 15746–15749 (1991).
Scherrer, K. Molec. Biol. Rep. 14, 1–9 (1990).
Heinemeyer, W., Kleinschmidt, J. A., Saidowsky, J., Escher, C. H. & Wolf, D. EMBO J. 10, 555–562 (1991).
Parham, P. Nature 360, 300–301 (1992).
Arnold, D. et al. Nature 360, 171–174 (1992).
Momburg, F. et al. Nature 360, 174–177 (1992).
Tanaka, K., li, K., Ichihara, A., Waxman, L. & Goldberg, A. L. J. biol. Chem. 261, 15197–15203 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gaczynska, M., Rock, K. & Goldberg, A. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365, 264–267 (1993). https://doi.org/10.1038/365264a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/365264a0
This article is cited by
-
Gastric cancer cell types display distinct proteasome/immunoproteasome patterns associated with migration and resistance to proteasome inhibitors
Journal of Cancer Research and Clinical Oncology (2023)
-
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Nature Reviews Cancer (2021)
-
Interleukin-12 elicits a non-canonical response in B16 melanoma cells to enhance survival
Cell Communication and Signaling (2020)
-
Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins
Scientific Reports (2020)
-
Proteasome subunit α1 overexpression preferentially drives canonical proteasome biogenesis and enhances stress tolerance in yeast
Scientific Reports (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.